NEPH
Nephros Inc
NASDAQ: NEPH · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$3.01
-4.74% today
Updated 2026-06-05
Market cap
$36.80M
P/E ratio
48.43
P/S ratio
1.93x
EPS (TTM)
$0.07
Dividend yield
—
52W range
$3 – $6
Volume
0.0M
Nephros Inc (NEPH) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$3.01
12-Month target
$2.31
2030 Target
—
Intrinsic (DCF)
$4.34
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 4.06%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.